Teladoc Health, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $781.1M | $1.30B | $1.12B | $918.2M | $893.5M | $733.3M | $514.4M | $424.0M |
| Accounts Receivable | $192.8M | $214.1M | $217.4M | $210.6M | $169.0M | $169.3M | $56.9M | $43.6M |
| Inventory | $38.2M | $38.1M | $29.5M | $56.3M | $73.1M | $56.5M | $0 | — |
| Total Current Assets | $1.12B | $1.66B | $1.49B | $1.32B | $1.23B | $1.06B | $588.0M | $532.7M |
| Property, Plant & Equipment | $27.0M | $29.5M | $32.0M | $29.6M | $27.2M | $28.6M | $10.3M | $10.1M |
| Goodwill | $283.2M | $283.2M | $1.07B | $1.07B | $14.50B | $14.58B | $746.1M | $737.2M |
| Intangible Assets (Excl. Goodwill) | $1.30B | $1.43B | $1.68B | $1.84B | $1.91B | $2.02B | $225.5M | $247.4M |
| Total Assets | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B |
| Liabilities | ||||||||
| Accounts Payable | $48.0M | $33.1M | $43.6M | $47.7M | $47.3M | $46.0M | $9.1M | $7.8M |
| Total Current Liabilities | $404.7M | $941.5M | $420.6M | $399.8M | $331.0M | $332.6M | $90.2M | $62.4M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $1.47B | $2.03B | $2.07B | $2.04B | $1.69B | $1.87B | $588.8M | $515.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-16.43B | $-16.23B | $-15.23B | $-15.01B | $-1.42B | $-992.7M | $-507.5M | $-408.7M |
| Total Stockholders' Equity | $1.39B | $1.49B | $2.33B | $2.31B | $16.05B | $15.88B | $1.01B | $1.01B |